The Id proteins and angiogenesis
The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Abstract
Since the identification of the Id proteins over a decade ago, a great many cell cycle and cell fate decisions have been shown to be under the control of these proteins as described in other sections of this review issue. Perhaps the most unsuspected activity of this class of proteins has been their essential role in angiogenesis, both in the forebrain during development and during the growth and metastasis of tumors in adults. This section of the review issue will focus on the key observations which have led to these conclusions, speculations about potential mechanisms and the outlook for potential therapeutic interventions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Expression of several of the Id proteins has been associated with tumour progression and several genetic studies suggest that the presence of Id factors is necessary for tumour vascularization through regulation of pro-angiogenic factors133,134.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [134]
In the citing paper
“Expression of several of the Id proteins has been associated with tumour progression and several genetic studies suggest that the presence of Id factors is necessary for tumour vascularization through regulation of pro-angiogenic factors133,134.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [134]
Citations
Cites
Isolation of Putative Progenitor Endothelial Cells for Angiogenesis
Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G., & Isner, J. M. (1997) · Science · doi:10.1126/science.275.5302.964 · Cited by 8,725 · cited 1×
“Several lines of evidence have suggested that vascular healing may be mediated in part by recruitment of CEPs (Asahara et al., 1997; Takahashi et al., 1999).”
BackgroundAngiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627 · cited 2×
“Tumor growth induces an angiogenic switch which involves proliferation, migration, and stabiliza- Oncogene tion of new blood vessels (Folkman, 1995; Folkman and Shing, 1992; Hanahan, 1997; Hanahan and Folkman, 1996; Pepper, 1997; Risau, 1997, Bergers et al., 1999; Hanahan and Folkman, 1996).”
BackgroundPatterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Risau, W. (1997) · Nature · doi:10.1038/386671a0 · Cited by 5,727 · cited 3×
“Tumor growth induces an angiogenic switch which involves proliferation, migration, and stabiliza- Oncogene tion of new blood vessels (Folkman, 1995; Folkman and Shing, 1992; Hanahan, 1997; Hanahan and Folkman, 1996; Pepper, 1997; Risau, 1997, Bergers et al., 1999; Hanahan and Folkman, 1996).”
BackgroundVascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 4,986 · cited 2×
“VEGF is a homodimeric, heparin-binding glycoprotein that is produced by almost every cell type (Leung et al., 1989).”
BackgroundAbnormal blood vessel development and lethality in embryos lacking a single VEGF allele
Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., et al. (1996) · Nature · doi:10.1038/380435a0 · Cited by 4,117 · cited 1×
“It is remarkable that mice with only a single allele of the VEGF gene (VEGF+/7) die between days 11 and 12 in utero because of impaired hematopoiesis and angiogenesis (Carmeliet et al., 1996; Ferrara et al., 1996).”
BackgroundFailure of blood-island formation and vasculogenesis in Flk-1-deficient mice
Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X.-F., Breitman, M. L., & Schuh, A. C. (1995) · Nature · doi:10.1038/376062a0 · Cited by 3,931 · cited 4×
“Most studies have shown that VEGFR2 is the critical receptor for transmitting cellular signals for the migration, proliferation and di erentiation of endothelial cells (Matthews et al., 1991; Ortega et al., 1997; Shalaby et al., 1995).”
BackgroundInfluentialHeterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J., & Moore, M. W. (1996) · Nature · doi:10.1038/380439a0 · Cited by 3,628 · cited 1×
“It is remarkable that mice with only a single allele of the VEGF gene (VEGF+/7) die between days 11 and 12 in utero because of impaired hematopoiesis and angiogenesis (Carmeliet et al., 1996; Ferrara et al., 1996).”
BackgroundFolkman, J., & Shing, Y. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49853-0 · Cited by 2,654
Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
Fong, G.-H., Rossant, J., Gertsenstein, M., & Breitman, M. L. (1995) · Nature · doi:10.1038/376066a0 · Cited by 2,606 · cited 2×
“In contrast, VEGFR1 knockout mice develop abnormal vascular channels, suggesting a role for this receptor in the regulation of endothelial cell ±matrix interactions (Fong et al., 1995).”
Background
Research works printed but not linked: 1
- Sun XH, Copeland NA, Jenkins NA, Baltimore D . 1991 Mol. Cell. Biol. 11: 5603–5611 · doi:10.1128/mcb.11.11.5603-5611.1991 · Paper page
Cited by
Vascular Endothelial Growth Factor and Angiogenesis
Hoeben, A., Landuyt, B., Highley, M. S., Wildiers, H., Van Oosterom, A. T., & De Bruijn, E. A. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.4.3 · Cited by 1,824
“There is comobilization of VEGFR-1 myeloid cells and EPCs, suggesting that these hematopoietic precursor cells are associated with the newly formed vessels and may be essential for the incorporation of EPCs (Benezra et al., 2001).”
BackgroundDe Palma, M., Venneri, M. A., Galli, R., Sergi, L. S., Politi, L. S., Sampaolesi, M., & Naldini, L. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.08.002 · Cited by 1,311
“Id mutant mice display both deficiencies in EC response to angiogenic stimuli and defective HC mobilization from the BM (Ruzinova et al., 2003; Volpert et al., 2002; Benezra et al., 2001).”
BackgroundCellular mechanisms of tumour suppression by the retinoblastoma gene
Burkhart, D. L., & Sage, J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2399 · Cited by 974
The H19 Non-Coding RNA Is Essential for Human Tumor Growth
Matouk, I. J., DeGroot, N., Mezan, S., Ayesh, S., Abu-lail, R., Hochberg, A., & Galun, E. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000845 · Cited by 650
“H19 RNA knockdown affects the hypoxic responsiveness of the potent angiogenic factors ANG [41], FGF18 [42], prolylcarboxypeptidase (PRCP) or angiotensinase c [43], tumor necrosis factor, alphainduced protein 1 (endothelial) (TNFAIP1) also known as (B61) [44] Calponin2 (CNN2) [45] and inhibitor of DNA binding 2 (Id2) […”
BackgroundTherapeutic targeting of the tumor microenvironment
Joyce, J. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.05.024 · Cited by 582
“Recent studies of endothelial cells (Benezra et al., 2001; Hoffman et al., 2003; Joyce et al., 2003) and stromal fibroblasts (Park et al., 1999; Bhowmick et al., 2004a, 2004b) have identi fied molecular differences between nontumor cells in the microenvironment of preneoplastic lesions compared to…”
Metadata
- Authors
- Benezra, R., Rafii, S., & Lyden, D.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- Cornell University (US)
- Corresponding author
- Benezra, Robert
- Venue
- Oncogene
- Published
- 2001-12-20
- Volume
- 20
- Issue
- 58
- Pages
- 8334-8341
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2028032755
- Cited by
- 222
- References
- 73
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 4 · 2022: 8 · 2021: 6 · 2020: 1 · 2019: 1 · 2018: 5 · 2017: 8 · 2016: 11 · 2015: 10 · 2014: 12 · 2013: 15 · 2012: 12
- FWCI
- 1.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Cancer Society
- Doris Duke Charitable Foundation
- Breast Cancer Research Foundation
- Leukemia and Lymphoma Society
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Keywords
- Id proteins, angiogenesis, cell cycle regulation, cell fate determination, forebrain development, tumor growth, metastasis, therapeutic target
- MeSH terms
- Animals, Blood Vessels, Bone Marrow Cells, Cell Differentiation, DNA-Binding Proteins, Dogs, Endothelium, Vascular, Multigene Family, Hematopoietic Stem Cells, Humans, Lymphokines, Neoplasm Proteins, Neoplasms, Neovascularization, Pathologic, Proto-Oncogene Proteins, Repressor Proteins, Stem Cells, Transcription Factors, Endothelial Growth Factors, Receptors, Growth Factor, Helix-Loop-Helix Motifs, Mice, Knockout, Neovascularization, Physiologic, Receptor Protein-Tyrosine Kinases, Receptors, Vascular Endothelial Growth Factor, Vascular Endothelial Growth Factor Receptor-1, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A, Mice, Inhibitor of Differentiation Proteins, Inhibitor of Differentiation Protein 2, Inhibitor of Differentiation Protein 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Id proteins and angiogenesis. https://app.cochat.ai/papers/10.1038/sj.onc.1205160
- The paper
- Benezra, R., Rafii, S., & Lyden, D. (2001). The Id proteins and angiogenesis. Oncogene. https://doi.org/10.1038/sj.onc.1205160
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.